Open-label, flexible-dose study of vortioxetine in patients with Major Depressive Disorder in India - NA
Latest Information Update: 21 Mar 2022
At a glance
- Drugs Vortioxetine (Primary)
- Indications Major depressive disorder
- Focus Adverse reactions
- Sponsors Lundbeck A/S
Most Recent Events
- 17 Mar 2022 Status changed from recruiting to completed.
- 22 Jun 2021 Planned End Date changed from 1 Nov 2021 to 18 Mar 2022.
- 22 Jun 2021 Planned primary completion date changed from 1 Nov 2021 to 18 Feb 2022.